Clinical Trials Browser

Advanced Lung Cancer × toripalimab × 90 days × Clear all

NCT07309276 2026-05-18

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

Phase 2 Recruiting

Advanced Lung Cancer